JPWO2022030606A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022030606A5
JPWO2022030606A5 JP2022518890A JP2022518890A JPWO2022030606A5 JP WO2022030606 A5 JPWO2022030606 A5 JP WO2022030606A5 JP 2022518890 A JP2022518890 A JP 2022518890A JP 2022518890 A JP2022518890 A JP 2022518890A JP WO2022030606 A5 JPWO2022030606 A5 JP WO2022030606A5
Authority
JP
Japan
Prior art keywords
group
methyl group
integer
hydrogen atom
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022518890A
Other languages
English (en)
Japanese (ja)
Other versions
JP7109705B2 (ja
JPWO2022030606A1 (cg-RX-API-DMAC7.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/029246 external-priority patent/WO2022030606A1/ja
Publication of JPWO2022030606A1 publication Critical patent/JPWO2022030606A1/ja
Publication of JPWO2022030606A5 publication Critical patent/JPWO2022030606A5/ja
Application granted granted Critical
Publication of JP7109705B2 publication Critical patent/JP7109705B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022518890A 2020-08-07 2021-08-06 新規なシクロアルケノン化合物又はその塩 Active JP7109705B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020135328 2020-08-07
JP2020135328 2020-08-07
PCT/JP2021/029246 WO2022030606A1 (ja) 2020-08-07 2021-08-06 新規なシクロアルケノン化合物又はその塩

Publications (3)

Publication Number Publication Date
JPWO2022030606A1 JPWO2022030606A1 (cg-RX-API-DMAC7.html) 2022-02-10
JPWO2022030606A5 true JPWO2022030606A5 (cg-RX-API-DMAC7.html) 2022-07-19
JP7109705B2 JP7109705B2 (ja) 2022-07-29

Family

ID=80118163

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022518890A Active JP7109705B2 (ja) 2020-08-07 2021-08-06 新規なシクロアルケノン化合物又はその塩

Country Status (11)

Country Link
US (1) US20230295068A1 (cg-RX-API-DMAC7.html)
EP (1) EP4194435A4 (cg-RX-API-DMAC7.html)
JP (1) JP7109705B2 (cg-RX-API-DMAC7.html)
KR (1) KR102974166B1 (cg-RX-API-DMAC7.html)
CN (1) CN116096361B (cg-RX-API-DMAC7.html)
AU (1) AU2021321705B2 (cg-RX-API-DMAC7.html)
BR (1) BR112023001832A2 (cg-RX-API-DMAC7.html)
CA (1) CA3188292A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023001536A (cg-RX-API-DMAC7.html)
TW (1) TWI829001B (cg-RX-API-DMAC7.html)
WO (1) WO2022030606A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023153422A1 (ja) * 2022-02-09 2023-08-17 大鵬薬品工業株式会社 シクロヘキセノン化合物の結晶形

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69811905T2 (de) 1997-08-13 2003-11-06 Meiji Milk Products Co. Ltd., Tokio/Tokyo Cyclohexenon langketten alkohol und diese enthaltendes arzneimittel
JP3836684B2 (ja) * 2001-02-19 2006-10-25 明治乳業株式会社 排尿障害治療剤
WO2009111576A2 (en) * 2008-03-05 2009-09-11 Edison Pharmaceuticals, Inc. 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
TWI501968B (zh) * 2010-11-12 2015-10-01 Merck Sharp & Dohme 六氫吡啶酮甲醯胺氮雜茚滿cgrp受體拮抗劑
CA2883879A1 (en) * 2012-09-07 2014-03-13 Edison Pharmaceuticals, Inc. Quinone derivatives for use in the modulation of redox status of individuals
EP3389646A1 (en) * 2015-12-17 2018-10-24 BioElectron Technology Corporation Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
RU2729186C2 (ru) 2016-01-22 2020-08-05 Тайхо Фармасьютикал Ко., Лтд. Способ производства длинноцепочечного спирта циклогексенона высокой степени очистки
TWI831738B (zh) * 2016-12-16 2024-02-11 美商瑞塔醫藥有限責任公司 用於抑制RORγ及其他用途的嘧啶三環烯酮衍生物

Similar Documents

Publication Publication Date Title
JP2024543976A5 (cg-RX-API-DMAC7.html)
JP2024543975A5 (cg-RX-API-DMAC7.html)
JP2013512277A5 (cg-RX-API-DMAC7.html)
CN113365998A (zh) 用于parp抑制剂的吲哚并七元酰肟类似物
JP2022533069A5 (cg-RX-API-DMAC7.html)
JP2010540508A5 (cg-RX-API-DMAC7.html)
JP2013508279A5 (cg-RX-API-DMAC7.html)
AU2005266529A1 (en) 1, 1a, 5, 5a-tetrahydro-3-thia-cyclopropa'a! pentalenes: tricyclic thiophene derivatives as S1P1/EDG1 receptor agonists
JP2018518537A5 (cg-RX-API-DMAC7.html)
RU2008127312A (ru) Мезилатное пролекарство леводопы, его композиции и применение
JP2019504898A5 (cg-RX-API-DMAC7.html)
JP2023535453A5 (cg-RX-API-DMAC7.html)
JP2011527333A5 (cg-RX-API-DMAC7.html)
JP2021512913A5 (cg-RX-API-DMAC7.html)
JP2010522710A5 (cg-RX-API-DMAC7.html)
JP2009541224A5 (cg-RX-API-DMAC7.html)
MA27390A1 (fr) Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
JP2014505017A5 (cg-RX-API-DMAC7.html)
JP2021513543A5 (cg-RX-API-DMAC7.html)
JP2019529460A5 (cg-RX-API-DMAC7.html)
ATE450496T1 (de) Verbindungen zur behandlung von stoffwechselstörungen
JP2015502371A5 (cg-RX-API-DMAC7.html)
JP2010535706A5 (cg-RX-API-DMAC7.html)
JP2009040767A5 (cg-RX-API-DMAC7.html)
JPWO2021187531A5 (cg-RX-API-DMAC7.html)